Propranolol
Propranolol is a pharmaceutical drug with 208 clinical trials. Currently 26 active trials ongoing. Historical success rate of 80.6%.
Success Metrics
Based on 100 completed trials
Phase Distribution
Phase Distribution
39
Early Stage
74
Mid Stage
56
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.2%
100 of 133 finished
24.8%
33 ended early
26
trials recruiting
208
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol: Effect on Psychophysiological Reactivity During Traumatic Imagery
Beta-Adrenergic Modulation of Drug Cue Reactivity
Adrenergic System in Islet Transplantation
Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study
Clinical Trials (208)
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol: Effect on Psychophysiological Reactivity During Traumatic Imagery
Beta-Adrenergic Modulation of Drug Cue Reactivity
Adrenergic System in Islet Transplantation
Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
A Study of Propranolol to Treat Kaposi Sarcoma
Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
Modafinil and Cognitive Function in POTS
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
Propranolol for Misophonia
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Shortening Duration of Antiarrhythmic Medication for SVT in Infants
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 208